Patrycja Jablonska
Gdansk, PM 80211, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Branched-Chain and Aromatic Amino Acids Mark Early Metabolic Shifts in Adults with Varying Adiposity.
Journal: International journal of molecular sciences
Published: May 27, 2026
Serum fatty acid profiles across clinicopathologic heterogeneity in breast cancer: an exploratory study.
Journal: Therapeutic advances in medical oncology
Published: October 27, 2025
Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
Journal: International journal of molecular sciences
Published: January 06, 2024
Serum fatty acid profiles in breast cancer patients following treatment.
Journal: BMC cancer
Published: December 05, 2022
Differences in Extracellular NAD+ and NMN Metabolism on the Surface of Vascular Endothelial Cells.
Journal: Biology
Published: March 07, 2022
The comparison of nucleotide metabolites and amino acids patterns in patients with eating disorders, with and without symptoms of depression.
Journal: Nucleosides, nucleotides & nucleic acids
Published: January 25, 2022
The decreased serum activity of cytosolic 5'-nucleotidase IA as a potential marker of breast cancer-associated muscle inflammation.
Journal: Nucleosides, nucleotides & nucleic acids
Published: November 24, 2021
Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation.
Journal: International journal of molecular sciences
Published: September 24, 2021
Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: February 28, 2021
Comparison of plasma nucleotide metabolites and amino acids pattern in patients with binge eating disorder and obesity.
Journal: Nucleosides, nucleotides & nucleic acids
Published: October 06, 2020
An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite.
Journal: Experimental & molecular medicine
Published: July 29, 2020
Last Updated: 09/26/2026